جستجوی استاد راهنمای دانشگاهی

Hutan Ashrafianمشاهده پروفایل

استاد

• Artificial Intelligence in Medicine
• Metabolic Surgery
• Health Policy
• +۴ مورد دیگر

Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.

Robert Rohlingمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Imaging
• Medical Information Systems
• +۳ مورد دیگر

Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.

Daniel Finleyمشاهده پروفایل

استاد

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +۷ مورد دیگر

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

Jillian Bohlenمشاهده پروفایل

دانشیار

• Animal Reproduction
• Dairy Science
• Reproductive Management
• +۵ مورد دیگر

Jillian Bohlen is an Associate Professor at the University of Georgia within the College of Agricultural & Environmental Sciences , specifically the Department of Animal and Dairy Science . Her work focuses on dairy cattle reproduction, teaching, and youth development in agricultural sciences. Education: B.S. in Dairy Science, University of Georgia (2003) M.S. in Dairy Science, University of Georgia (2005) Ph.D. in Animal Sciences, Clemson University (2012) Dr. Bohlen's research emphasizes applied reproduction in cattle , including synchronization techniques, ultrasound applications in reproductive programs, and embryo competency. She integrates students into all research projects despite lacking a formal research appointment. Her teaching interests span dairy cattle production , reproductive management , and contemporary agricultural issues , with courses like ADSC 3620 (Dairy Cattle Production), ADSC 4010 (Issues in Animal Agriculture), and ADSC 4410 (Applied Reproductive Management). Scientific awards include: Student Career Success Influencer Award (2024) Russell Award for Excellence in Undergraduate Teaching (2023) UGA Creative Teaching Award (2022) CAES Early Career Teaching Award (2022) Hoard's Dairyman Youth Development Award (2021) Larry Benyshek Teaching Award (2017) She actively promotes agricultural education through programs like the Commercial Heifer Project , Dairy Cattle Judging , and Dairy Quiz Bowl . Additionally, she participates in funded projects related to methane emissions , heat stress mitigation , and antibiotic alternatives in dairy farming.

• Fibrosis Research
• Liver Fibrosis
• Kidney Fibrosis
• +۹ مورد دیگر

Karen Piper Hanley is Professor of Molecular Medicine and Head of Division in the Division of Diabetes, Endocrinology & Gastroenterology at the University of Manchester. She serves as the fibrosis lead in the Wellcome Trust Centre for Cell-Matrix Research and previously served as Director of Core Research Technologies (2019-2022). She is also an editorial board member for Scientific Reports. Her research focuses on fibrosis (scarring) mechanisms across multiple organs, particularly liver, kidney, and lung fibrosis. Her lab investigates the cellular and molecular basis of fibrotic disease, with emphasis on how pathological scar components are produced and how they signal to surrounding cells. Key areas include the role of SOX9 transcription factor, integrin beta-1 signaling, Group 1 PAKs, and YAP1 in fibrosis progression. Her recent publications reveal trends toward increased clinical translation of fibrosis research, with studies on health inequalities in liver cancer care, post-COVID diabetes incidence, and innovative approaches to liver disease detection. Her work increasingly integrates spatial transcriptomics and advanced omics technologies to understand cellular transitions in liver disease. Career-track postdoctoral fellowship from the University of Southampton (2006) As senior postgraduate tutor, she has mentored numerous PhD students who have presented at key conferences and authored high-quality manuscripts. All her PhD students have submitted and been awarded their degrees within 4 years. She has successfully guided previous Academic Clinical Fellows to win MRC clinical training fellowships. Her teaching extends to undergraduate Personal & Professional Development and supervision of MRes and BSc students, many of whom have achieved first-class degrees and prestigious awards. Her lab maintains active collaborations with Professor Neil Hanley's group on human development, stem cells, and regenerative medicine, bridging developmental biology with fibrosis research to understand why regeneration is impaired in chronic diseases.

• RNA Biology
• Myeloid Malignancies
• Hematology
• +۴ مورد دیگر

Dr. Giulia Biancon is an Assistant Professor Adjunct in the Department of Medical Oncology and Hematology at Yale School of Medicine. She holds a PhD from the University of Milan (2019) and is a member of the Halene Lab, focusing on RNA biology and hematologic malignancies. Her research combines high-throughput methodologies to study RNA mechanisms in diseases like myeloid leukemias and splicing factor mutations. Education: PhD in Molecular Biology from the University of Milan (2019). Research Interests: RNA splicing, stress granules in cancer, epitranscriptomics, clonal hematopoiesis, and the interplay between genetic mutations and cellular pathways in blood cancers. Awards: 2024 Eclipse Award, 2022 ASH Abstract Achievement Award, and 2022 RNA Society Best Poster Award. Her work has been published in journals like Cell Reports , Blood , and Molecular Cell . Labs/Teams: Principal member of the Halene Lab and coordinator at the Yale Center for RNA Science and Medicine. Collaborates with institutions like the SeroNet network for immunology studies.

Hai-Quan Maoمشاهده پروفایل

استاد

• Biomaterials
• Regenerative Engineering
• Therapeutic Delivery
• +۳ مورد دیگر

Hai-Quan Mao is a Professor of Materials Science and Engineering at Johns Hopkins University, with a joint appointment in the Biomedical Engineering Department (School of Medicine). He directs the Institute for NanoBioTechnology (INBT) and leads the Translational Tissue Engineering Center. His research focuses on biomaterials, regenerative engineering, and immunoengineering, particularly developing nanomaterials for therapeutic delivery and tissue regeneration. Mao holds 35 U.S. patents, co-founded two biotech companies, and received prestigious awards including National Academy of Inventors Fellow and NSF CAREER Award. Education: BS in Chemistry (1988) and PhD in Polymer Chemistry (1993) from Wuhan University. Postdoctoral training at Johns Hopkins (1995–1998), followed by roles at Johns Hopkins Singapore (1999–2003) before joining the Whiting School faculty. Research emphasizes nanofiber scaffolds for liver/nerve regeneration, DNA/lipid nanoparticle engineering for gene therapy, and artificial lymph node matrices for immunotherapy. His lab translates biomaterials innovations into clinical applications, with NIH-funded projects addressing cancer, malaria, and tissue damage. Awards include over 60 provisional patents, multiple Johns Hopkins translational awards, and Thalheimer Awards for research. He serves as associate editor of Biomaterials and editorial board member of major journals. Lab activities include scalable nanoparticle manufacturing, machine learning for material design, and collaborations with industry/clinical partners. Recent work includes lipid nanoparticle optimization for mRNA vaccines and exosome-based therapies for Crohn’s disease.

• Drug Delivery
• Nanomedicine
• Biopharmaceutics
• +۷ مورد دیگر

Dr. Shyh-Dar Li is a Professor and Tong Louie Chair in Pharmaceutical Sciences at the University of British Columbia's Faculty of Pharmaceutical Sciences, where he also serves as Chair of Nanomedicine and Chemical Biology. With a BSc in pharmacy from National Taiwan University (1998) and PhD in pharmaceutical sciences from UNC Chapel Hill (2008), followed by postdoctoral training at UC San Diego's Moores Cancer Center (2009), Dr. Li has established himself as a leading researcher in advanced drug delivery systems. His research focuses on developing innovative nanomedicine platforms for targeted delivery of biological therapeutics including peptides, proteins, antibodies, and nucleic acids. Dr. Li's laboratory has pioneered several novel drug delivery approaches, particularly in lipid-based nanoparticles, phospholipid-free vesicles, and polymer systems for cancer immunotherapy, pain management, and protein delivery. His work bridges fundamental nanotechnology with translational applications for difficult-to-treat diseases. Analysis of his recent publications reveals a strong emphasis on tumor microenvironment modulation, endosomal escape mechanisms for nucleic acid delivery, and non-invasive delivery routes for protein therapeutics. His research demonstrates increasing sophistication in nanocarrier engineering, with recent work incorporating machine learning approaches to optimize nanoparticle design and expanding into immunomodulatory therapies that harness the body's immune system to fight cancer. Scientific Recognition: 2014 AFPC New Investigator Award 2013 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies 2013 CIHR New Investigator Award 2013 CSPS Early Career Award 2012 Prostate Cancer Foundation Young Investigator Award Dr. Li's research program has been consistently supported by major Canadian funding agencies including CIHR, NSERC, and MITACS. He actively collaborates across disciplines and accepts graduate students into his research program, focusing on cutting-edge approaches to overcome biological barriers in drug delivery. His laboratory, the Laboratory of Targeted Drug Delivery and Nanomedicine, serves as a hub for innovation in pharmaceutical nanotechnology.

• Pharmacology
• Traditional Chinese Medicine
• Cancer Therapy
• +۷ مورد دیگر

Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.

Helmuth Gehartمشاهده پروفایل

استاد

• Stem Cell Biology
• Cancer Biology
• Regenerative Medicine
• +۲ مورد دیگر

Prof. Dr. Helmuth Gehart is a faculty member at the Institute of Molecular Health Sciences , ETH Zurich . He leads the Tumor and Stem Cell Dynamics research group, focusing on dynamic cell identity in regeneration and cancer. Research Interests : Stem cell-environment interactions, organoid technology, single-cell sequencing, and mechanisms of tissue repair/tumorigenesis. Publications : 10+ articles (2015-2024) on organoid models, stem cell dynamics, and cancer biology.

• Pharmacoepidemiology
• Drug Safety
• Diabetes Mellitus
• +۳ مورد دیگر

Björn Pasternak is a Research Professor leading the Pharmacoepidemiology group at the Department of Medicine, Solna, Karolinska Institutet. His team specializes in large-scale registry studies focused on adverse drug effects, with research programs in pediatric pharmacoepidemiology, safety of diabetes medications, and rapid assessment of drug safety concerns. The group leverages high-quality epidemiological methods to inform evidence-based clinical decisions. Pasternak's research interests span pharmacoepidemiology, drug safety, diabetes outcomes, cardiovascular risk, and perinatal health. His work utilizes nationwide registries to evaluate real-world drug effects, socioeconomic disparities in treatment, and long-term outcomes of chronic therapies. Key focuses include GLP-1 receptor agonists, SGLT2 inhibitors, antibiotic use in pregnancy, and opioid safety. Recent publications demonstrate strong emphasis on Scandinavian cohort studies of diabetes medications (GLP-1 agonists, SGLT2 inhibitors) and their associations with thyroid cancer, liver events, intestinal obstruction, and cardiovascular/renal outcomes. Other trends include perinatal pharmacovigilance (antibiotics, acid-suppressive drugs) and neurodegenerative risks in athletes.

Waldemar Kolanusمشاهده پروفایل

استاد

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

Jeremy Dahlمشاهده پروفایل

استاد

• Medical Ultrasound Imaging
• Ultrasonic Beamforming
• Image Reconstruction
• +۷ مورد دیگر

Jeremy Dahl is a Professor of Radiology (Pediatric Radiology) at Stanford University School of Medicine. He directs the Ultrasound Imaging & Instrumentation Lab and serves as Director of Research Academic Affairs in the Department of Radiology since 2020. He holds multiple affiliations across Stanford including Bio-X, the Cardiovascular Institute, Wu Tsai Human Performance Alliance, Maternal & Child Health Research Institute, Stanford Cancer Institute, and Wu Tsai Neurosciences Institute. Dr. Dahl received his B.S. in Electrical Engineering from the University of Cincinnati (1999) and Ph.D. in Biomedical Engineering from Duke University (2004). His research focuses on developing ultrasonic beamforming and image reconstruction methods for diagnostic imaging applications, particularly techniques that generate high-quality images in difficult-to-image patients. His laboratory specializes in B-mode and Doppler imaging techniques that utilize additional information from ultrasonic wavefields to improve image quality and develop real-time imaging systems for clinical applications including cardiac, liver, and fetal imaging. Dr. Dahl's research has led to significant advancements in ultrasound molecular imaging platforms, sound speed estimation, aberration correction, and reverberation noise suppression. His work often bridges engineering innovation with clinical applications for cancer detection and other diseases. His recent publications demonstrate strong focus on machine learning applications in ultrasound, distributed aberration correction, and molecular imaging techniques. Fellow, American Institute of Ultrasound in Medicine (2021) Senior Member, Institute of Electrical and Electronics Engineers (2020) Distinguished Investigator Award, The Academy for Radiology & Biomedical Imaging Research (2018) Outstanding Paper Award, IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society (2011) Dr. Dahl serves in editorial roles for major journals including IEEE Transactions on Medical Imaging (2017-2024) and IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control (2013-Present). His laboratory has successfully translated numerous innovations into clinical applications, with multiple patents including recent developments in pulsed focused ultrasound therapy and speed of sound quantification.

• Medical Microwave Imaging
• Microwave Engineering
• Millimeter-wave Engineering
• +۳ مورد دیگر

Professor Amin Abbosh is a faculty member at the School of Electrical Engineering and Computer Science, University of Queensland. His research focuses on Medical Microwave Imaging and Millimeter-wave Engineering, with contributions to advanced imaging systems, antenna design, and communication technologies. He leads projects in electromagnetic medical sensing, including portable brain scanners and wearable diagnostic systems. His work integrates applied electromagnetics with AI-driven algorithms, addressing challenges in stroke detection, liver health monitoring, and deep vein thrombosis diagnosis. With over 16 patents and collaborations across biomedical and engineering domains, his research bridges clinical needs with cutting-edge electromagnetic techniques. Key projects include the development of low-cost healthcare monitoring systems and reconfigurable antennas for satellite communications. Research interests span medical imaging systems, antenna array design, and signal processing for healthcare applications. His team innovates in areas like phased arrays, dielectric property analysis, and non-invasive diagnostics. Recent advancements include synthetic microwave focusing techniques and self-supervised deep learning models for clutter removal in imaging. Publications highlight contributions in IEEE journals and conferences, emphasizing clinical applications and device prototyping. Collaborations with institutions like the University of Queensland’s medical faculty and industry partners ensure practical implementation of his research.

Levent Burak Karaمشاهده پروفایل

استاد

• Machine Learning
• Artificial Intelligence
• Computational Design
• +۱۲ مورد دیگر

Levent Burak Kara is a Professor in the Department of Mechanical Engineering at Carnegie Mellon University (CMU), with a courtesy appointment in the Robotics Institute. He is a leading researcher in AI-driven computational design, additive manufacturing, and intelligent engineering systems, leading the Visual Design and Engineering Lab (VDEL) at CMU. Education: B.S., Mechanical Engineering, Middle East Technical University (1998) M.S., Mechanical Engineering, Carnegie Mellon University (2000) Ph.D., Mechanical Engineering, Carnegie Mellon University (2005) His research focuses on integrating machine learning, optimization, and geometric modeling to revolutionize engineering design and manufacturing. Key areas include topology optimization, CAD intelligence, digital twins, generative design, bioengineering, and electronic design automation. His work enables automation of traditionally labor-intensive design processes using deep learning and reinforcement learning. His recent publications reveal a strong trend toward physics-informed surrogate modeling, real-time simulation, manufacturability prediction, and AI-driven automation in mechanical, biomedical, and electronic systems. These works frequently appear in top journals such as Journal of Mechanical Design and Journal of Applied Mechanics , and at premier conferences like NeurIPS and DAC. Scientific Awards: National Science Foundation CAREER Award ASME Design Automation Society Young Investigator Award Google AI for Social Good Impact Scholar Kara advises several Ph.D. students and has secured significant funding from federal agencies such as the NSF and the U.S. Army Research Laboratory, as well as collaborations with industrial leaders including Cadence Design Systems and NVIDIA. His research is also supported by CMU’s NextManufacturing Center and the Critical Technology Initiative. He is actively involved in developing intelligent design systems that leverage AI to automate product design, optimize manufacturing processes, and improve medical diagnostics, particularly in oral cancer screening and organ preservation. His lab, VDEL, is a hub for innovation in AI-enabled engineering.